论文部分内容阅读
阿尼西坦、脑复康、淀粉随机对照治疗脑外伤后记忆减退患者９０例。每组各３０例，分别服阿尼西坦胶囊０．２ｇ／次，脑复康片０．８ｇ／次，淀粉０．２ｇ／次，均３次／ｄ；共４周。结果临床总有效率阿尼西坦组８６．７％，脑复康组６３．３％，二组有显著差异（Ｐ＜０．０５）；阿尼西坦组记忆商平均增值为１５±９（Ｐ＜０．０１），脑复康组平均增值１０±７（Ｐ＜０．０１），两组间经ｔ检验有显著差异（Ｐ＜０．０５），说明阿尼西坦组疗效优于脑复康组，不良反应轻微，可以选用。
Aniracetam, Naofukang, Starch Randomized Controlled Treatment of 90 Patients with Memory Depression after Traumatic Brain Injury. Each group of 30 patients, respectively, serving aniracetam capsules 0.2g / times, Naofukang tablets 0.8g / times, starch 0.2g / time, were 3 times / d; a total of 4 weeks. Results The total clinical effective rate was 86.7% in aniracetam group and 63.3% in naofukang group, with significant difference between the two groups (P <0.05). The mean value of memory in aniracetam group was 15 ± 9 (P <0.01). The average recovery of Naofukang group was 10 ± 7 (P <0.01). There was significant difference between the two groups (P <0.05) by t test, which indicated that the efficacy of Aniracetam group was superior In the brain rehabilitation group, minor adverse reactions, you can use.